Clinical Aspects and Molecular Analysis of Chinese Patients with Wiskott-Aldrich Syndrome in TaiwanLee W.-I.a, b · Yang C.-Y.a · Jaing D.-H.c · Huang J.-L.a, b · Chien Y.-H.e · Chang K.-W.d
aImmunodeficiency Diagnosis and Research Institute, bDepartment of Pediatric Allergy, Immunology and Rheumatology, Hematology, cDepartment of Pediatric Hematology and Oncology and dDepartment of Pediatric Gastroenterology, Chang Gung Memory Hospital and University College of Medicine, Taoyuan, and eDepartments of Pediatrics and Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency, characterized by microthrombocytopenia, eczema and recurrent infections. More than 441 patient mutations have been described all over the world, mainly based on Caucasian and Japanese people. There have been few reported cases involving Chinese WAS patients. Objective: We investigated Chinese WAS patients in Taiwan since 1980. Methods: All WAS patients met the diagnosis criteria. Clinical manifestations, immunological functions, gene sequencing and the WAS protein (WASP) expression were analyzed. Results: Eleven male Chinese WAS patients were enrolled, presenting as classic WAS phenotype, correlative to the expression level of WASP and the severity of infections. Seven patients had autoimmune disorders, encompassing autoimmune hemolysis in 4, lymphoproliferative disorders in 2 and ulcerative colitis in 1 patient. As well as prophylactic monthly intravenous immunoglobulin infusion, splenectomy was performed on 2 patients. Five patients received hematopoietic stem cell transplantation. The causes of mortality were mass bleeding, sepsis and Epstein Barr virus-associated lymphoproliferative disorders in 3 nontransplant patients and acute graft failure and cytomegalovirus pneumonitis in 2 transplant patients. Nine patients received genetic analysis and revealed 4 unique mutations. None had the X-linked thrombocytopenia phenotype. Conclusions: All of the recognized Chinese WAS patients had the classic phenotype. Most mutations involved exon 1 of the WASP gene and none had the X-linked thrombocytopenia phenotype. This may be attributable to genetic variation, although selection bias may exist.
© 2007 S. Karger AG, Basel
Wiskott A: Familiärer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd 1937;68:212–216.
- Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA: A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994;125:876–885.
- Perry GS 3rd, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, Krivit W, Kersey JH: The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 1980;97:72–78.
- Derry JM, Ochs HD, Francke U: Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635–644.
- Wengler GS, Notarangelo LD, Berardelli S, Pollonni G, Mella P, Fasth A, Ugazio AG, Parolini O: High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 1995;86:3648–3654.
- Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD: Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 1997;90:2680–2689.
- Lemahieu V, Gastier JM, Francke U: Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum Mutat 1999;14:54–66.
- Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S: Clinical course of patients with WASP gene mutations. Blood 2004;103:456–464.
- Schindelhauer D, Weiss M, Hellebrand H, Golla A, Hergersberg M, Seger R, Belohradsky BH, Meindl A: Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet 1996;98:68–76.
- Tong YH, Sinniah D, Murugasu R, White JC: Two Malaysian Chinese male children with the Wiskott-Aldrich syndrome. Singapore Med J 1979;20:355–359.
- Lin CY, Hsu HC: Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant. Ann Allergy 1984;53:74–78.
- Lau YL, Jones BM, Low LC, Wong SN, Leung NK: Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome. Eur J Pediatr 1992;151:680–683.
- Lau YL, Wong SN, Lawton WM: Takayasu’s arteritis associated with Wiskott-Aldrich syndrome. J Paediatr Child Health 1992;28:407–409.
- Huang MT, Chou CC, Jou ST, Lin KH, Hsieh KH: Successful bone marrow transplantation in a Chinese boy with Wiskott-Aldrich syndrome. Asian Pac J Allergy Immunol 1996;14:57–63.
- Chien YH, Hwu WL, Ariga T, Chang KW, Yang YH, Lin KH, Chiang BL: Molecular diagnosis of Wiskott-Aldrich syndrome in Taiwan. J Microbiol Immunol Infect 2004;37:276–281.
- Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, Chen SH, Ochs HD: The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 1995;86:3797–3804.
- Ochs HD: The Wiskott-Aldrich syndrome. Isr Med Assoc J 2002;4:379–384.
- Levitt D, Ochs H, Wedgwood RJ: Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM. J Clin Immunol 1984;4:143–150.
Lee WI, Kuo ML, Huang JL, Lin SJ, Wu CJ: Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol 2005;18:162–172.
- Stewart DM, Treiber-Held S, Kurman CC, Facchetti F, Notarangelo LD, Nelson DL: Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest 1996;97:2627–2634.
- Yamaguchi K, Ariga T, Yamada M, Nelson DL, Kobayashi R, Kobayashi C, Noguchi Y, Ito Y, Katamura K, Nagatoshi Y, Kondo S, Katoh H, Sakiyama Y: Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood 2002;100:1208–1214.
- Yang YL, Lu MY, Jou ST, Lin KH, Lin DT: Hematopoietic stem cell transplantation in Taiwanese children with primary immunodeficiency. J Formos Med Assoc 2005;104:101–106.
- Den Dunnen JT, Antonarakis SE: Nomenclature for the description of human sequence variation. Hum Genet 2001;109:121–124.
- Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, Gandellini F, Stewart DM, Zhu Q, Nelson DL, Notarangelo LD, Ochs HD : Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004;104:4010–4019.
- Imai K, Nonoyama S, Ochs HD: WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol 2003;3:427–436.
- Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA, Bucher-Laurent S, Delenda C, Vainchenker W, Danos O, Galy A: A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 2005;12:597–606.
- Chinen J, Puck JM: Perspectives of gene therapy for primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2004;4:523–527.
- Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringden O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM: Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001;97:1598–1603.
- Lam DS, Lee TL, Chan KW, Ho HK, Lau YL: Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis. Hong Kong Med J 2005;11:90–96.
- Knutsen AP, Steffen M, Wassmer K, Wall DA: Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J Pediatr 2003;142:519–523.
- Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE: Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999:340:508–516.
- Zhao HJ, Chen TX, Hao YQ, Zhou YF, Ying DM: Overview of clinical occurrence of primary immunodeficiency disorders in children. Zhonghua Er Ke Za Zhi 2006;44:403–406.
- Lim DL, Thong BY, Ho SY, Shek LP, Lou J, Leong KP, Chng HH, Lee BW: Primary immunodeficiency diseases in Singapore – the last 11 years. Singapore Med J 2003;44:579–586.
- Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL: Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol 2006;26:274–283.
- Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG, et al: X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 1995;9:414–417.
- Tornai I, Kiss A, Laczko J: Wiskott-Aldrich syndrome in a heterozygous carrier woman. Eur J Haematol 1989;42:501–502.
- Notarangelo LD, Parolini O, Porta F, Locatelli F, Lanfranchi A, Marconi M, Nespoli L, Albertini A, Craig IW, Ugazio AG: Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS. Hum Genet 1991;88:237–241.
- De Weers M, Mensink RG, Kraakman ME, Schuurman RK, Hendriks RW: X chromosome inactivation patterns in leucocyte populations of female carriers of Wiskott-Aldrich syndrome with an atypical presentation. Immunodeficiency 1993;4:267–269.
- De Saint Basile G, Lagelouse RD, Lambert N, Schwarz K, Le Mareck B, Odent S, Schlegel N, Fischer A: Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J Pediatr 1996;129:56–62.
- Parolini O, Ressmann G, Haas OA, Pawlowsky J, Gadner H, Knapp W, Holter W: X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med 1998;338:291–295.
- Ariga T, Yamada M, Wada T, Saitoh S, Sakiyama Y: Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome. Br J Haematol 1999;104:893–900.
- Inoue H, Kurosawa H, Nonoyama S, Imai K, Kumazaki H, Matsunaga T, Sato Y, Sugita K, Eguchi M: X-linked thrombocytopenia in a girl. Br J Haematol 2002;118:1163–1165.
- Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O’Donnell E: Wiskott-Aldrich syndrome in a female. Blood 2002;100:2763–2768.
- Andreu N, Pujol-Moix N, Martinez-Lostao L, Oset M, Muniz-Diaz E, Estivill X, Volpini V, Fillat C: Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells Mol Dis 2003;31:332–337.
- Conley ME, Wang WC, Parolini O, Shapiro DN, Campana D, Siminovitch KA: Atypical Wiskott-Aldrich syndrome in a girl. Blood 1992;80:1264–1269.
- Russell SJ, Nisen PD: Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome. Br J Haematol 1995;90:210–212.
- Kondoh T, Hayashi K, Matsumoto T, Yoshimoto M, Morio T, Yata J, Tsuji Y: Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: is the condition in the family autosomal recessive? Am J Med Genet 1995;60:364–369.
- Kondoh T, Matsumoto T, Tsuji Y: Wiskott-Aldrich syndrome in two sisters. Am J Med Genet 1997;74:218–219.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.